| Hordinsky, Maria |
| Completed | 3 | 10 | US | Diphenylcyclopropenone (DPCP) Ointment | University of Minnesota, National Alopecia Areata Foundation | Alopecia Areata | 09/24 | 09/24 | | |
SCALP1, NCT05910450: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss |
|
|
| Recruiting | 3 | 726 | US, RoW | Clascoterone 5% solution, CB-03-01 5% solution, Vehicle solution, Vehicle | Cassiopea SpA, Ergomed PLC, Pharmapace Inc, Canfield Scientific Inc., ICON Clinical Research | Alopecia, Androgenetic | 10/24 | 04/25 | | |
BRAVE-AA-PEDS, NCT05723198: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata |
|
|
| Recruiting | 3 | 595 | Europe, Canada, Japan, US, RoW | Baricitinib, LY3009104, Placebo | Eli Lilly and Company | Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical | 09/24 | 08/29 | | |
BRAVE-AA1, NCT03570749: A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata |
|
|
| Active, not recruiting | 2/3 | 824 | Japan, US, RoW | Baricitinib, LY3009104, Placebo | Eli Lilly and Company, Incyte Corporation | Alopecia Areata | 02/21 | 01/25 | | |
|
|
| Completed | 1 | 15 | US | Cellular Matrix TM BCT-HA Kit (ref. BCT-HA-3), PRP Only, Placebo | University of Minnesota | Rhytides, Wrinkle | 10/23 | 02/24 | | |
NCT00177073: Alopecia Areata Registry and Immunogenetic Mechanisms |
|
|
| Recruiting | N/A | 2000 | US | questionnaires, Alopecia areata universalis/totalis. | University of Minnesota - Clinical and Translational Science Institute, M.D. Anderson Cancer Center, Columbia University, University of Colorado, Denver, University of California | Alopecia Areata | 12/13 | 12/14 | | |
NCT06357169: Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias |
|
|
| Terminated | N/A | 1 | US | Venus Glow | University of Minnesota | Lichen Planopilaris of Scalp, Alopecia Areata | 06/23 | 01/24 | | |
NCT03335228: Platelet Rich Plasma for Frontal Fibrosing Alopecia |
|
|
| Not yet recruiting | N/A | 20 | US | Eclipse Easy Spin for PRP | University of Minnesota | Frontal Fibrosing Alopecia | 09/25 | 09/26 | | |
NCT05319444: Cleansing Device for the Treatment of Scalp and Hair Conditions |
|
|
| Recruiting | N/A | 40 | US | Off-brand Waterpik® | University of Minnesota | Dandruff, Seborrheic Dermatitis, Hair Loss | 11/25 | 11/25 | | |
| Recruiting | N/A | 15000 | Europe, Canada, US | | Target PharmaSolutions, Inc. | Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria | 12/50 | 12/50 | | |
| Thenappan, Thenappan |
NCT05983250: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF |
|
|
| Recruiting | 3 | 152 | Canada, US | TNX-103, Placebo | Tenax Therapeutics, Inc., Medpace, Inc., Northwestern University | Pulmonary Hypertension | 03/27 | 07/27 | | |
NCT04884971: Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study |
|
|
| Completed | 1 | 11 | US | Intestinal microbiota transplant (IMT) | University of Minnesota | Pulmonary Arterial Hypertension | 12/23 | 12/23 | | |
NCT06481852: A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension |
|
|
| Recruiting | 1 | 24 | US | MTT with antibiotic preconditioning + fiber supplementation, MTT with antibiotic preconditioning + placebo supplementation, MTT with placebo + placebo supplementation. | University of Minnesota | Pulmonary Arterial Hypertension | 09/26 | 09/26 | | |
| Recruiting | N/A | 1500 | Europe, US, RoW | assessment of pulmonary hemodynamics during exercise by right heart catheterization | Medical University of Graz, European Respiratory Society | Pulmonary Circulation Diseases | 12/29 | 12/29 | | |
ASPIRE PH, NCT04555161: Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System |
|
|
| Recruiting | N/A | 30 | US | Aria CV Pulmonary Hypertension System, Aria CV PH System | Aria CV, Inc | Pulmonary Arterial Hypertension, Pulmonary Hypertension, Right Heart Dysfunction | 10/24 | 10/26 | | |
| Recruiting | N/A | 3000 | US | | Pulmonary Hypertension Association, Inc., University of Washington, the Collaborative Health Studies Coordinating Center | Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension | 10/25 | 10/25 | | |
| Bezerra, Hiram |
| Not yet recruiting | N/A | 15 | US | TricValve® Transcatheter Bicaval Valve System, TricValve System | P+F Products + Features USA Inc., P+F Products + Features GmbH, Meditrial USA Inc. | Tricuspid Regurgitation, Tricuspid Valve Disease | 11/25 | 11/29 | | |
| Recruiting | N/A | 150 | US | HF-OCT Imaging, FFR Pressure Wire, Angiography | Gentuity, LLC | Coronary Stenosis | 12/24 | 12/24 | | |
| Recruiting | N/A | 15 | US | AltaValve | 4C Medical Technologies, Inc. | Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Incompetence, Mitral Valve Regurgitation, Mitral Incompetence | 09/25 | 09/25 | | |
APOLLO, NCT03242642: Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. |
|
|
| Recruiting | N/A | 1056 | Europe, Canada, US | Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR) | Medtronic Cardiovascular | Mitral Valve Regurgitation | 10/26 | 09/36 | | |
| Vinod, Thourani |
APOLLO, NCT03242642: Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. |
|
|
| Recruiting | N/A | 1056 | Europe, Canada, US | Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR) | Medtronic Cardiovascular | Mitral Valve Regurgitation | 10/26 | 09/36 | | |
